On Tuesday, Travere Therapeutics Inc (NASDAQ: TVTX) opened higher 4.76% from the last session, before settling in for the closing price of $14.6. Price fluctuations for TVTX have ranged from $7.93 to $25.29 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company slipped by -3.34% over the past five years. Company’s average yearly earnings per share was noted 73.28% at the time writing. With a float of $87.44 million, this company’s outstanding shares have now reached $88.79 million.
Let’s look at the performance matrix of the company that is accounted for 385 employees. In terms of profitability, gross margin is 92.23%, operating margin of -81.81%, and the pretax margin is -82.6%.
Travere Therapeutics Inc (TVTX) Insider Updates
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Travere Therapeutics Inc is 1.54%, while institutional ownership is 112.72%. The most recent insider transaction that took place on Jul 01 ’25, was worth 11,940. In this transaction CHIEF MEDICAL OFFICER of this company sold 815 shares at a rate of $14.65, taking the stock ownership to the 88,787 shares. Before that another transaction happened on May 05 ’25, when Company’s CHIEF FINANCIAL OFFICER sold 1,784 for $21.05, making the entire transaction worth $37,553. This insider now owns 93,126 shares in total.
Travere Therapeutics Inc (TVTX) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.06 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 73.28% per share during the next fiscal year.
Travere Therapeutics Inc (NASDAQ: TVTX) Trading Performance Indicators
Check out the current performance indicators for Travere Therapeutics Inc (TVTX). In the past quarter, the stock posted a quick ratio of 2.03. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 4.97.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.80, a number that is poised to hit -0.30 in the next quarter and is forecasted to reach 0.50 in one year’s time.
Technical Analysis of Travere Therapeutics Inc (TVTX)
Travere Therapeutics Inc (NASDAQ: TVTX) saw its 5-day average volume 1.21 million, a negative change from its year-to-date volume of 1.69 million. As of the previous 9 days, the stock’s Stochastic %D was 67.06%.
During the past 100 days, Travere Therapeutics Inc’s (TVTX) raw stochastic average was set at 21.02%, which indicates a significant decrease from 97.93% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.61 in the past 14 days, which was lower than the 1.00 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $16.78, while its 200-day Moving Average is $17.92. Nevertheless, the first resistance level for the watch stands at $15.52 in the near term. At $15.75, the stock is likely to face the second major resistance level. The third major resistance level sits at $16.16. If the price goes on to break the first support level at $14.88, it is likely to go to the next support level at $14.47. Assuming the price breaks the second support level, the third support level stands at $14.24.
Travere Therapeutics Inc (NASDAQ: TVTX) Key Stats
There are currently 88,805K shares outstanding in the company with a market cap of 1.36 billion. Presently, the company’s annual sales total 233,180 K according to its annual income of -321,550 K. Last quarter, the company’s sales amounted to 81,730 K and its income totaled -41,230 K.
